Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics, Pharmacodynamics,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03351738
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease

Who this might be right for
Stable Coronary Heart Disease
MedImmune LLC 133
Early research (Phase 1)Looking for participantsNCT06349473
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

Who this might be right for
Healthy ParticipantsHemophilia AHemophilia B+1 more
Equilibra Bioscience LLC 31
Testing effectiveness (Phase 2)Study completedNCT00184951
What this trial is testing

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

Who this might be right for
HIV InfectionsHyperlipidemia
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07461181
What this trial is testing

Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital 10
Early research (Phase 1)Ended earlyNCT00929370
What this trial is testing

A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.

Who this might be right for
Schizophrenia
GlaxoSmithKline 34
Testing effectiveness (Phase 2)Study completedNCT00291356
What this trial is testing

GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2Non-Insulin-Dependent Diabetes Mellitus
GlaxoSmithKline 45
Early research (Phase 1)Study completedNCT04593251
What this trial is testing

Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis

Who this might be right for
Eosinophilic EsophagitisCeliac Disease
Calypso Biotech BV 73
Early research (Phase 1)Looking for participantsNCT06801002
What this trial is testing

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

Who this might be right for
Solid Tumor
Jabez Bioscience, Inc 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07386002
What this trial is testing

The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
T-MAXIMUM Pharmaceutical Inc 40
Early research (Phase 1)Study completedNCT01488201
What this trial is testing

A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Kyowa Kirin Co., Ltd. 48
Early research (Phase 1)Study completedNCT05654181
What this trial is testing

A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult Participants

Who this might be right for
Healthy
Pfizer 20
Early research (Phase 1)Ended earlyNCT04045028
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaB-Cell Lymphoma
Genentech, Inc. 41
Early research (Phase 1)Ended earlyNCT00946972
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 33
Early research (Phase 1)Ended earlyNCT03483077
What this trial is testing

This Study in Healthy Volunteers Determines the Amount of BI 730460 in the Blood When Taken as Tablet. It Looks at How Different Doses of BI 730460 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How Food Influences the Amount of BI 730460 in the Blood.

Who this might be right for
Healthy
Boehringer Ingelheim 48
Early research (Phase 1)Study completedNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 115
Testing effectiveness (Phase 2)Study completedNCT05228470
What this trial is testing

Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

Who this might be right for
ElranatamabMyelomaMultiple Myeloma+8 more
Pfizer 39
Testing effectiveness (Phase 2)Study completedNCT01474083
What this trial is testing

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
vTv Therapeutics 248
Early research (Phase 1)Study completedNCT01308541
What this trial is testing

Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion

Who this might be right for
Monitored Anesthesia Care
Eisai Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT02898753
What this trial is testing

VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease

Who this might be right for
Pompe Disease
Valerion Therapeutics, LLC 12
Early research (Phase 1)Study completedNCT03990519
What this trial is testing

A Single Subcutaneous Dose of JNJ-26366821 in Healthy Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 33
Next Page